FDA Approves First Fecal Transplant Pill

SER-109 is the second human feces-derived treatment to be approved by the FDA. The first was Rebyota in December of 2022.

Nejm
NEJM

C. diff is a bacterial infection that can cause severe diarrhea and inflammation of the colon, and it often recurs even after treatment with antibiotics. According to a recent LIFE-SCIENCE article, the FDA has approved the first-ever pill made from human feces for the treatment of recurrent Clostridioides difficile (C. diff) infection. The pill, called "SER-109," contains spores from multiple strains of bacteria found in healthy feces that can help restore the gut microbiome and fight off C. diff infections.

Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026